Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Bispecific Antibodies

Research Grade Faricimab (HT073016)

Price(USD): $
Spec:
  • 100ug
  • 1mg
Number:
Contact us
  • Overview
  • Images
  • References
  • Datasheet
Overview
Catalog No.HT073016
Species reactivityHuman
ApplicationsELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host speciesHumanized
IsotypeIgG1-kappa-lambda
Expression systemMammalian Cells
ClonalityMonoclonal
TargetVascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A, ANG-2, ANGPT2, Angiopoietin-2
Endotoxin levelPlease contact the lab for this information.
Purity>95% purity as determined by SDS-PAGE.
PurificationProtein A/G purified from cell culture supernatant.
AccessionP15692 & O15123
FormLiquid
Storage buffer20 mM His, 140mM NaCl, pH6.0
Stability and StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate NamesBispecific, RG7716, RO6867461, 1607793-29-2
BackgroundZifibancimig is an anti-VEGFA/ANGPT2 IgG1κ monoclonal antibody.
NoteFor research use only. Not suitable for clinical or therapeutic use.
Images
  • SDS-PAGE

    SDS-PAGE for Research Grade Faricimab.

  • Bioactivity

    Detects Human ANGPT2 in indirect ELISAs.

  • Bioactivity

    Detects VEGFA in indirect ELISAs.

  • Bioactivity

    Detects Recombinant Human VEGFA/VEGF165 Protein, C-His (Cat No.: HB941011) in indirect ELISA.

Recommendation